Dec. 9, 2019—The Enabling Innovation Initiative presents Kayla Graff, CEO and co-founder of SweetBio, who will discuss “Million Dollar Lessons: Attracting Capital to Fuel Your Biotech/Scientific Startup” on Friday, Dec. 13, beginning at 2 p.m. in Light Hall, Room 512.
Dec. 5, 2019—Poorly functioning AMPARs have been linked to a wide range of neurological and psychiatric disorders including seizures, Alzheimer’s disease, major depression and autism spectrum disorder. Understanding how AMPARs are formed and operate is essential for the rational design of pharmacological compounds that, by tuning AMPAR activity up or down, could improve treatment of these conditions.
Dec. 4, 2019—The identification of a protein important for insulin synthesis may hold clues for understanding the pathogenesis of diabetes.
Nov. 1, 2019—Reginald Cannady, a postdoctoral research fellow at the Medical University of South Carolina, will discuss “Probing Novel Targets to Reduce Heavy Drinking in Models of Alcohol Use Disorder” at 4 p.m. Tuesday, Nov. 12, in Light Hall, Room 512, as part of the Discovery Science Emerging Scholars Lecture Series.
Nov. 1, 2019—Researchers at Vanderbilt's Biomolecular Multimodal Imaging Center are working to create a high-resolution, three-dimensional “atlas” of the human kidney that will help future researchers understand what exactly goes wrong when kidneys fail.
Oct. 30, 2019—Gary J. Nabel, chief scientific officer and senior vice president of Sanofi, will discuss “Unlocking the Promise of Medicine through Academic and Biotech/Pharma Innovation” at 11 a.m. Friday, Nov. 15, in Light Hall, Room 512. The lecture is part of the School of Medicine Basic Science's Enabling Innovation Initiative seminar series.
Oct. 16, 2019—The Department of Cell and Developmental Biology will present a special seminar on Thursday, Oct. 24. Annarita Scaramozza, a postdoctoral scholar at the University of California-San Francisco, will present “Muscle Stem Cell Under Stress” beginning at 12:15 p.m. in MRB III, Room 3131.